Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Pediatric Hodgkin Lymphoma, Version 3.2021.

Publication ,  Journal Article
Flerlage, JE; Hiniker, SM; Armenian, S; Benya, EC; Bobbey, AJ; Chang, V; Cooper, S; Coulter, DW; Cuglievan, B; Hoppe, BS; Isenalumhe, L ...
Published in: J Natl Compr Canc Netw
June 30, 2021

Hodgkin lymphoma (HL) is a highly curable form of cancer, and current treatment regimens are focused on improving treatment efficacy while decreasing the risk of late effects of treatment. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for pediatric HL provide recommendations on the workup, diagnostic evaluation, and treatment of classic HL, including principles of pathology, imaging, staging, systemic therapy, and radiation therapy. This portion of the NCCN Guidelines focuses on the management of pediatric classic HL in the upfront and relapsed/refractory settings.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

June 30, 2021

Volume

19

Issue

6

Start / End Page

733 / 754

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Oncology & Carcinogenesis
  • Medical Oncology
  • Humans
  • Hodgkin Disease
  • Child
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Flerlage, J. E., Hiniker, S. M., Armenian, S., Benya, E. C., Bobbey, A. J., Chang, V., … Campbell, M. (2021). Pediatric Hodgkin Lymphoma, Version 3.2021. J Natl Compr Canc Netw, 19(6), 733–754. https://doi.org/10.6004/jnccn.2021.0027
Flerlage, Jamie E., Susan M. Hiniker, Saro Armenian, Ellen C. Benya, Adam J. Bobbey, Vivian Chang, Stacy Cooper, et al. “Pediatric Hodgkin Lymphoma, Version 3.2021.J Natl Compr Canc Netw 19, no. 6 (June 30, 2021): 733–54. https://doi.org/10.6004/jnccn.2021.0027.
Flerlage JE, Hiniker SM, Armenian S, Benya EC, Bobbey AJ, Chang V, et al. Pediatric Hodgkin Lymphoma, Version 3.2021. J Natl Compr Canc Netw. 2021 Jun 30;19(6):733–54.
Flerlage, Jamie E., et al. “Pediatric Hodgkin Lymphoma, Version 3.2021.J Natl Compr Canc Netw, vol. 19, no. 6, June 2021, pp. 733–54. Pubmed, doi:10.6004/jnccn.2021.0027.
Flerlage JE, Hiniker SM, Armenian S, Benya EC, Bobbey AJ, Chang V, Cooper S, Coulter DW, Cuglievan B, Hoppe BS, Isenalumhe L, Kelly K, Kersun L, Lamble AJ, Larrier NA, Magee J, Oduro K, Pacheco M, Price AP, Roberts KB, Smith CM, Sohani AR, Trovillion EM, Walling E, Xavier AC, Burns JL, Campbell M. Pediatric Hodgkin Lymphoma, Version 3.2021. J Natl Compr Canc Netw. 2021 Jun 30;19(6):733–754.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

June 30, 2021

Volume

19

Issue

6

Start / End Page

733 / 754

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Oncology & Carcinogenesis
  • Medical Oncology
  • Humans
  • Hodgkin Disease
  • Child
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis